Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Grzepnica

3 clinical trials in Grzepnica, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Grzepnica at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Grzepnica

Open in trial search

Endometrial cancer+5

Recruiting

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB

Ovarian cancer

Not recruiting

Study of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB

Neoplasm malignant+1

Not recruiting

Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Grzepnica

What the registry says about research in the country

01 Advanced Solid Tumors

Innovative research focusing on advanced solid malignancies through the evaluation of novel therapeutic approaches. These trials explore treatment options for patients with various types of solid tumors.

  • Treatment Development
  • Monotherapy Assessment
  • Combination Therapy Studies

Research aims to establish safety profiles and evaluate potential therapeutic benefits for patients with advanced cancers.

02 Ovarian Cancer Research

Groundbreaking studies examining treatment options for patients with BRCA-mutated ovarian cancer, particularly focusing on maintenance therapy following platinum-based chemotherapy.

  • BRCA Mutation Studies
  • Post-Chemotherapy Care
  • Disease Progression Monitoring

Trials evaluate treatment effectiveness using modified RECIST criteria for accurate assessment of patient responses.

03 Multi-Cancer Studies

Comprehensive research program investigating treatments across multiple cancer types, including ovarian, breast, pancreatic, prostate, and endometrial cancers.

  • Extended Treatment Access
  • Long-term Safety Monitoring
  • Multi-Cancer Approach

These studies focus on providing continued access to beneficial treatments while maintaining careful safety surveillance.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.